Skip to main content
. 2020 Nov 6;21(1):15. doi: 10.3892/ol.2020.12276

Table III.

KRAS and NRAS analysis of plasma samples.

RAS status No. of patients (%)
Wild-type KRAS 7 (22.58)
Mutated KRAS 22 (77.42)
  Exon 2 codon 12 17 (77.27)
  Exon 2 codon 13 4 (18.18)
  Exon 3 codon 59 0 (0.00)
  Exon 3 codon 61 0 (0.00)
  Exon 4 codon 117 0 (0.00)
  Exon 4 codon 146 1 (4.55)
Not informative 2
  Total 31
Wild-type NRAS 24 (77.42)
Mutated NRAS 6 (22.58)
  Exon 2 codon 12 2 (33.33)
  Exon 2 codon 13 0 (0.00)
  Exon 3 codon 59 0 (0.00)
  Exon 3 codon 61 4 (66.67)
  Exon 4 codon 117 0 (0.00)
  Exon 4 codon 146 0 (0.00)
  Not informative 1
  Total 31